PMC (PHARMERICA CORP)
All Pro Portfolios with PMC
- Total Pro Portfolios with PMC:
- Turner Emerging Growth TMCGX
- Greenlight Capital - David Einhorn
- show more
All Do-It-Yourself Portfolios with PMC
- Total Do-It-Yourself Portfolios with PMC:
- rod's picks
- zaxareos Portfolio 1
- ajacobs18 Portfolio 1
- Cramer's Take On Ladies Night Stock Picks
- Barron's Interview John Keeley Jr.
- cdm1
- show more
- 12
- citism
- Ted DiBiase Portfolio 1
- PART 7 JPMorgan 26th Annual Healthcare Conf 1/10/08..4th Day Reporting Companies..Nymph Take
- Cramer's Take on Top 10 Most Searched Stocks from 7-29-08
- Cramer's Take on Top 10 Most Searched Stocks from 8-8-08
- PART 4 JPMorgan 27th Annual Healthcare Conf 1/13/09..2nd Day Reporting Companies..Nymph Take
- News For Selected Stock
- Related stories on theStreet.com
- videos related to etf's
- No videos found
- blogs related to etf's
- No blogs found
Why I Love This Stock |
|
Date:12 30 08 |
|
4:30 |
|
Not yet rated
Rate now:
|
|
By:sarah z |
Date:08 10 08 |
From a recent Mad Money show: |
|
Not yet rated
Rate now:
|
|
By:barrons2 |
Date:08 09 08 |
Some spinoffs that undergo additional restructuring are also are of interest to Keeley. The firm bought Louisville, Ky.-based PharMerica (PMC), which was created in 2007 from the merger of two leading institutional pharmacy businesses -- PharMerica Long-Term Care and Kindred Pharmacy Services. PharMerica Long-Term was spun out from AmerisourceBergen (ABC), a drug wholesaler. It then was merged with Kindred. The new company operates 115 institutional pharmacies that service 340,000 beds. "So in addition to the benefits of a spinoff and restructuring, you have a demographic play as the population ages," says health-care specialist Woodyatt. Small Cap Value bought it in April at around 15. It has since risen to about 24. The Street estimates earnings of 78 cents a share this fiscal year and $1.04 next year. |
|
Not yet rated
Rate now:
|
|
By:sarah z |
Date:07 29 08 |
From a recent Mad Money show: |
|
Not yet rated
Rate now:
|
|
By:barrons2 |
Date:02 14 08 |
Cramer put PharMerica (PMC) in the "don't buy" camp. This company is too new and unseasoned to invest in, he said, adding he saw no compelling reason to take on the extra risk. |
|
Not yet rated
Rate now:
|
|
Why I Hate This Stock |
|
| Comments not available |
